BACKGROUND AND STUDY AIMS: @entity10457 is a key component of bowel preparation regimen for colon capsule endoscopy (CCE), but may cause serious complications. The aim of this study is to evaluate the use of @entity3989 , substituted for @entity10457 , in CCE bowel preparation. @entity1 AND METHODS: In total, 29 @entity1 (median age 64 years; 23 females) underwent CCE, covered by the national health insurance system of Japan. All had a history of laparotomy and/or previously incomplete colonoscopy. On the day before examination, @entity1 ingested 1L of @entity968 + @entity620 with 0.5L of water in the evening, and again the same laxative on the morning of examination. After capsule ingestion, 50mL of @entity3989 diluted with 0.9L of @entity19068 was administered, and then repeated after 1 hour. RESULTS: The capsule excretion rate was 97% (28/29). The median colon transit time was 2 hours 45 minutes and rapid transit (<40 minutes) through the colon occurred in one @entity1 (3.4%). Bowel cleansing level was adequate in 90% of @entity1 . The @entity1127 (>= 6mm) detection rate was 52%. Diluted @entity3989 was well tolerated by @entity1 . No adverse events occurred. CONCLUSION: @entity3989 can be an alternative to @entity10457 in CCE bowel preparation regimen.

@entity3989 as an alternative booster to XXXX in colon capsule endoscopy: safety and efficacy pilot study.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS'] @entity1127 :: ('MESH:D011127', 'Disease') :: ['polyp'] @entity620 :: ('MESH:D001205', 'Chemical') :: ['ascorbic acid'] @entity3989 :: ('MESH:D003974', 'Chemical') :: ['Gastrografin'] @entity10457 :: ('MESH:C018279', 'Chemical') :: ['sodium phosphate', 'Sodium phosphate'] @entity19068 :: ('MESH:C110422', 'Chemical') :: ['magnesium citrate'] @entity968 :: ('MESH:D011092', 'Chemical') :: ['polyethylene glycol']
@entity10457 :: (MESH:C018279,Chemical) :: ['sodium phosphate']
